Acurx Pharmaceuticals (ACXP)

• Market cap: $16M
• 1 day: -15.54%
• 5 days: 43.22%
• 1 month: 237.35%
• 3 months: 62.32%
• 6 months: 37.25%
• Year to date: 102.9%
• 1 year: -33.17%
• 5 years: -96.45%
• 10 years: -96.45%
• Sector: Healthcare
• Industry: Biotechnology

About: Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Employees: 4